RELN and Alzheimer disease: We determined that the 420 kDa full-length reelin exhibited a pronounced reduction in the CSF of AD patients, whilst the 310 kDa N-terminal fragment presented a striking increase, suggesting a boosted rate of reelin proteolysis; however, the major N-terminal fragment of 180 kDa did not appear to be altered.